Cargando…

Is Fecal Calprotectin an Applicable Biomarker of Gut Immune System Activation in Chronic Inflammatory Demyelinating Polyneuropathy? – A Pilot Study

Introduction: Chronic inflammatory demyelinating polyneuropathy (CIDP) is a complex autoimmune disease caused by dysregulated response to not fully recognized antigens. Some association between CIDP and inflammatory bowel disease (IBD) has been reported, but the exact pathophysiological links of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koszewicz, Magdalena, Mulak, Agata, Dziadkowiak, Edyta, Budrewicz, Sławomir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8636096/ https://www.ncbi.nlm.nih.gov/pubmed/34867240 http://dx.doi.org/10.3389/fnhum.2021.733070

Ejemplares similares

Fecal Calprotectin as a Marker of the Gut Immune System Activation Is Elevated in Parkinson’s Disease
por: Mulak, Agata, et al.
Publicado: (2019)

Correlations between Electrophysiological Parameters, Lymphocyte Distribution and Cytokine Levels in Patients with Chronic Demyelinating Inflammatory Polyneuropathy
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Pathology of Initial Axon Segments in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Related Disorders
por: Dziadkowiak, Edyta, et al.
Publicado: (2022)

miR-31-5p as a Potential Circulating Biomarker and Tracer of Clinical Improvement for Chronic Inflammatory Demyelinating Polyneuropathy
por: Dziadkowiak, Edyta, et al.
Publicado: (2023)

Pathophysiology of the Different Clinical Phenotypes of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Abnormality of multimodal evoked potentials in chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)
por: Dziadkowiak, Edyta, et al.
Publicado: (2020)

The Usefulness of Quantitative EEG and Advanced MR Techniques in the Monitoring and Long-Term Prognosis of Lance-Adams Syndrome
por: Szczepańska, Aleksandra, et al.
Publicado: (2019)

Molecular, Electrophysiological, and Ultrasonographic Differences in Selected Immune-Mediated Neuropathies with Therapeutic Implications
por: Dziadkowiak, Edyta, et al.
Publicado: (2023)

Calprotectin in Chronic Inflammatory Demyelinating Polyneuropathy and Variants—A Potential Novel Biomarker of Disease Activity
por: Stascheit, Frauke, et al.
Publicado: (2021)

Validity and reliability of the Polish version of the Michigan Neuropathy Screening Instrument
por: Sutkowska, Edyta, et al.
Publicado: (2023)

The Use of Quantitative Sensation Testing to Identify the Physiological Differences Between the Median and Ulnar Nerves
por: Koszewicz, Magdalena, et al.
Publicado: (2021)

Monogenic Causes of Strokes
por: Chojdak-Łukasiewicz, Justyna, et al.
Publicado: (2021)

Depression with Chronic Inflammatory Demyelinating Polyneuropathy
por: Marwale, Arun, et al.
Publicado: (2018)

Intravenous immunoglobulin for inflammatory demyelinating polyneuropathy
por: Talaei, M., et al.
Publicado: (2021)

Brainstem auditory evoked potentials in patients with primary Sjögren’s syndrome without central nervous system involvement
por: Waliszewska-Prosół, Marta, et al.
Publicado: (2020)

Multisequence Quantitative Magnetic Resonance Neurography of Brachial and Lumbosacral Plexus in Chronic Inflammatory Demyelinating Polyneuropathy
por: Su, Xiaoyun, et al.
Publicado: (2021)

Fecal Zonulin as a Noninvasive Biomarker of Intestinal Permeability in Pediatric Patients with Inflammatory Bowel Diseases—Correlation with Disease Activity and Fecal Calprotectin
por: Szymanska, Edyta, et al.
Publicado: (2021)

Fecal calprotectin in inflammatory bowel disease
por: Walsham, Natalie E, et al.
Publicado: (2016)

Visual Evoked Potentials as Potential Biomarkers of Visual Function in Patients with Primary Sjögren’s Syndrome
por: Dziadkowiak, Edyta, et al.
Publicado: (2021)

Tailoring of therapy for chronic inflammatory demyelinating polyneuropathy
por: Rajabally, Yusuf A.
Publicado: (2015)

Challenges in the diagnosis of chronic inflammatory demyelinating polyneuropathy
por: Allen, Jeffrey A., et al.
Publicado: (2018)

The dilemma of diabetes in chronic inflammatory demyelinating polyneuropathy
por: Bril, Vera, et al.
Publicado: (2016)

Neurofascin and Compact Myelin Antigen-Specific T Cell Response Pattern in Chronic Inflammatory Demyelinating Polyneuropathy Subtypes
por: Diederich, Jan-Markus, et al.
Publicado: (2018)

Impact of Neurofascin on Chronic Inflammatory Demyelinating Polyneuropathy via Changing the Node of Ranvier Function: A Review
por: Gao, Ying, et al.
Publicado: (2021)

Elevated fecal levels of the inflammatory biomarker calprotectin in early systemic sclerosis
por: Hamberg, Viggo, et al.
Publicado: (2022)

Multimodal Evoked Potentials as Potential Biomarkers of Disease Activity in Patients With Clinically Isolated Syndrome
por: Dziadkowiak, Edyta, et al.
Publicado: (2022)

Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?
por: Kato, Jun, et al.
Publicado: (2016)

A98 FECAL LEUKOCYTE ESTERASE: AN ALTERNATIVE BIOMARKER TO FECAL CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE
por: Klemm, N K, et al.
Publicado: (2022)

IRIS manifesting as chronic inflammatory demyelinating polyneuropathy in HIV
por: Reghukumar, Aravind, et al.
Publicado: (2014)

Chronic inflammatory demyelinating polyneuropathy associated with diabetes mellitus
por: Fatehi, Farzad, et al.
Publicado: (2013)

Fibrillary glomerulonephritis combined with chronic inflammatory demyelinating polyneuropathy
por: Sung, Woo Kyung, et al.
Publicado: (2015)

Corneal confocal microscopy in chronic inflammatory demyelinating polyneuropathy
por: Stettner, Mark, et al.
Publicado: (2015)

Inflammatory demyelinating polyneuropathy after total hip arthroplasty
por: Hess, Shane R., et al.
Publicado: (2018)

Evolving Immunologic Perspectives in Chronic Inflammatory Demyelinating Polyneuropathy
por: Rajabally, Yusuf A, et al.
Publicado: (2020)

Treatment-related fluctuations in subacute inflammatory demyelinating polyneuropathy
por: Min, Young Gi, et al.
Publicado: (2020)

Underdiagnosis and diagnostic delay in chronic inflammatory demyelinating polyneuropathy
por: Chaudhary, Umair J., et al.
Publicado: (2020)

Subcutaneous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy
por: Goyal, Namita A., et al.
Publicado: (2021)

Peripheral Nerve Enlargement in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tanitame, Keizo, et al.
Publicado: (2020)

Reversible conduction failure in acute inflammatory demyelinating polyneuropathy
por: Kim, Sooyoung, et al.
Publicado: (2022)

Nerve Ultrasound Score in Chronic Inflammatory Demyelinating Polyneuropathy
por: Tan, Cheng-Yin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_023dij9att7oulno57usavnubv